m-Tolylacetic acid → HCID 70976210, compound
Reaction equation
[NH2:1][N:2]1[N:11]=[C:10]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][CH2:13]2)[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[C:3]1=[O:18].[CH3:19][C:20]1[CH:21]=[C:22]([CH2:26][C:27](O)=[O:28])[CH:23]=[CH:24][CH:25]=1>>[CH3:19][C:20]1[CH:21]=[C:22]([CH2:26][C:27]([NH:1][N:2]2[N:11]=[C:10]([N:12]3[CH2:17][CH2:16][O:15][CH2:14][CH2:13]3)[C:9]3[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=3)[C:3]2=[O:18])=[O:28])[CH:23]=[CH:24][CH:25]=1Participants
3
Procedure
The product of Example 1B and 2-(3-methylphenyl)acetic acid were treated using a method similar to that described in Example 111 to give the title compound. 1H NMR (500 MHz, DMSO-d6/D2O) δ 8.31 (d, J=7.9, 1H), 8.04-8.01 (m, 1H), 8.01-7.96 (m, 1H), 7.94-7.88 (m, 1H), 7.26-7.22 (m, 1H), 7.19-7.16 (s, 2H), 7.11-7.08 (t, J=9.0, 1H), 3.86-3.78 (m, 4H), 3.62 (s, 2H), 3.13-3.06 (m, 4H), 2.31 (s, 3H); MS (ESI+) M/Z 379 (M+H)+.
Sources & evidence
- ORD record
- ord-4adb591112724ee19db751d5e134f2b5
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08859549B2
Reaction notes
Loading…